CS Paper Radar

Cross-disorder Learning of Imaging-derived Joint Mophometric Markers in Alzheimer's and Parkinson's Diseases

Yuji Zhao, Boris Gutman

cs.LG q-bio.QMq-bio.NC ·submitted 2026-10-19 18:44 UTC · v1
code/datahot direction

Abstract

As two most prevalent neurodegenerative diseases (NDDs), Alzheimer's disease (AD) and Parkinson's disease (PD) shared commonalities both in symptomology and pathophysiology. However, to what extent and in what way these two distinct disorders overlap remain underexplored. In this study, we propose an explicit, interpretable and spatially adaptive transfer learning framework to elucidate the morphometric biomarkers linked to AD and PD. We applied such high-dimensional machine learning model to two most popular open-source neuroimaging datasets, i.e., Alzheimer's Disease Neuroimaging Initiative (ADNI) and Parkinson's Progression Markers Initiative (PPMI). On the one hand, our cross-disorder classifier revealed neuro-anatomical alteration patterns well aligning with previous neuroimaging research findings and underscoring patients' clinical presentations. On the other hand, the spatially adaptive trained classifier using shared prior achieved statistically superior diagnostic performance compared to respective individual models, which further highlights the cross-disorder framework's efficacy on modeling limited-size datasets across disease domains.

Closest papers

Nearest neighbours by meaning across the whole index.

Emergence of Transfer Learning towards Specific Identification of Alzheimer's Disease A Prospective Approach

cs.CV cs.DL ·2026-08-13 ·Soumik Podder, Chandramouli Haldar
published similarity 0.68
Abstract

Worldwide, millions of senior citizens are suffering from Alzheimer disease abbreviated as AD, a well- versed form of dementia. AD is featured by amnesia, intellectual disability, and difficulty with consciousness. DL and ML models are undoubtedly explored to identify AD related patterns on large dimensional neuroimaging data but they need global optimization and are suffering from overfitting issue that might yield dissatisfactory result in testing data set. DL overcomes the issue by convolution of input image with kernel but any sudden change in the MRI image or human manipulation, limited pre- processing of the images can mislead CNN in achieving highly accurate detection. Transfer Learning (TL) has proved itself in AD diagnosis by utilizing pre-trained models on large data sets to guide novice model in a new neuroimaging dataset. This review provides an inclusive glimpse of TL implication in classification, identification including the conversion of AD. Keeping in view, we have assessed the strengths and limitations of TL in improvising diagnostic accuracy even with limited data. The uniqueness of the present review is the incorporation of explainable AI in TL based AD diagnosis system. Finally, it can be claimed that the review will guide the new re-searchers in the area of TL induced neurodegenerative disease detection.

0.58

Improving the Clinical Generalizability of Machine Learning-Based Alzheimer's Disease Detection Across Domains and Modalities: A Comprehensive Review

eess.AS ·2026-11-05 ·Yingchao Huang, Yuhan Su, Xin Wang, Shanshan Yao
published similarity 0.65
Abstract · This paper has been accepted by the Journal of Alzheimer's Disease

Objective: This review aims to provide a comprehensive synthesis of domain adaptation (DA) and domain general- ization (DG) strategies for AD detection. It focuses on their potential to improve the robustness, generalizability, and clinical reliability of ML-based diagnostic systems. Methods: We conduct a comprehensive scoping review of existing DA and DG approaches across multiple data modalities. The reviewed studies are organized according to data modality, algorithmic framework, adaptation strat- egy, clinical relevance, and reported cross-domain performance. Key methodological trends, performance gains, limitations, and remaining challenges are analyzed to identify future research directions. Results: DA and DG approaches have demonstrated encouraging improvements in cross-domain performance and model robustness. Emerging modalities, such as speech-based approaches, EEG and eye-tracking data, show great po- tential for early, accessible, and non-invasive cognitive assessments. However, important limitations remain, including insufficient external validation, limited interpretability, computational complexity, privacy concerns, and challenges in scaling to routine clinical practice. Conclusion: DA and DG provide important methodological pathways for developing more generalizable ML-based systems for AD detection. Future research should prioritize explainable, computationally efficient, privacy-preserving, and clinically validated DA/DG techniques. Strengthening these aspects will be essential for translating robust AI- based AD detection tools into clinically deployable solutions.

0.22

HybridDualPathNet: Cross-Fusion Attention of EfficientNetV2 and Swin Transformer for Brain MRI Classification of Alzheimer's and Parkinson's Disease

cs.CV cs.LGcs.SE ·2026-10-12 ·Jarpula Nirjala, Rahul Patel
similarity 0.65
Abstract · Two experimental settings: Kaggle-only image-level evaluation and combined Kaggle and ADNI evaluation with patient-wise separation for ADNI …

Separating Alzheimer's Disease (AD), Parkinson's Disease (PD), and Healthy Controls (HC) using structural MRI remains challenging because disease signatures overlap and model performance can be strongly affected by data partitioning. We present HybridDualPathNet, a hybrid architecture combining EfficientNetV2-S for local features and Swin-Tiny for global context through a Cross-Fusion Attention (CFA) module. We evaluate the model in two experiments. First, on the Kaggle APD-3-Class dataset using an image-level split, the model achieves 98.25% accuracy. Second, on a combined Kaggle and Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset containing 17,859 slices, we use a per-source split with patient-wise separation for ADNI subjects. In this setting, the model achieves 73.37% standard accuracy and a macro AUC of 0.880. Source-stratified evaluation reveals a substantial domain gap, with 91.2% accuracy on Kaggle test images and 59.2% on ADNI test images. Temperature scaling reduces expected calibration error from 0.130 to 0.015, while split-conformal prediction achieves 89.5% coverage. Saliency analyses using Grad-CAM++, Integrated Gradients, and occlusion indicate that model activations concentrate on brain tissue. These results highlight the importance of patient-level separation, cross-dataset evaluation, and uncertainty estimation when assessing MRI classification systems. The findings also show that strong performance on a single dataset does not necessarily translate to reliable generalization across imaging cohorts.

0.13

Longitudinal Bayesian Learning of Continuous Disease Position across the Alzheimer's Disease Continuum

cs.LG cs.AIq-bio.QM ·2026-08-19 ·Yingying Zhang, Kun Zhao, Guodong Liu, Qi Huang, Pengfei Gu +8 more
similarity 0.64
Abstract

Alzheimer's disease (AD) progresses as a continuous biological process, whereas most existing neuroimaging-based artificial intelligence methods remain limited to discrete diagnosis or clinical score prediction from cross-sectional imaging. In this work, we propose Disease Continuum Positioning (DCP), a longitudinal Bayesian Learning framework that continuously estimates disease severity from longitudinal diffusion tensor imaging (DTI). Specifically, DCP models disease severity as a low-dimensional probabilistic latent variable by jointly integrating longitudinal observations with weak clinical supervision, from which the proposed Disease Continuum Score (DCS) is derived to quantify an individual's position along the Alzheimer's disease continuum together with its associated uncertainty. Extensive experiments on the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort demonstrate that DCP consistently outperforms representative disease progression methods. More importantly, comprehensive validation analyses show that DCS accurately characterizes disease severity, exhibits strong clinical relevance, preserves longitudinal disease evolution, and predicts future disease conversion. These results suggest that DCS provides a quantitative imaging-derived representation for continuous assessment of Alzheimer's disease progression beyond conventional diagnostic labels and clinical scores.

0.19

Leveraging a Foundation Model for the EEG-Based Diagnosis of Alzheimer's Disease

cs.LG q-bio.NC ·2026-08-27 ·Maggie Lin, Chung-Lin Hou, Tzyy-Ping Jung
published similarity 0.64
Abstract · 7 pages, 9 figures, 1 table. Accepted and presented at the 48th Annual International Conference of the IEEE Engineering in Medicine and Biol…

Biological heterogeneity in Alzheimer's Disease (AD) poses a critical diagnostic challenge, particularly for traditional linear methods that fail to capture non-linear neural dynamics. To address this, we propose a diagnostic framework utilizing the Large Brain Model (LaBraM), pretrained on over 2,500 hours of EEG data. By integrating these high-dimensional latent embeddings with a non-linear Random Forest classifier, our approach effectively isolates robust disease markers. Under a rigorous subject-independent 5-fold cross-validation protocol, the method achieves an ROC-AUC of 89.36% +/- 3.49%, PR AUC of 81.45% +/- 4.43%, and Balanced Accuracy of 82.44% +/- 4.34% in distinguishing dementia patients from healthy controls. Notably, this performance uses only 8-second EEG segments, surpassing traditional spectral baselines, including band-power and parameterized oscillatory features (FOOOF). Post-hoc occlusion analysis confirms the model captures clinically validated biomarkers, specifically occipital-frontal Alpha and Theta rhythm degradation. Additional neurophysiological alignment analysis demonstrated that higher LaBraM-predicted dementia probability significantly correlated with worse cognitive performance, greater clinical severity, increased theta and alpha relative power, and higher aperiodic exponent. These findings demonstrate that deep latent representations extract clinically relevant signatures from noisy signals, enabling precise, rapid, and data-efficient diagnosis.

0.30

Anatomical Grounding and Leakage-Aware Multimodal Contrastive Learning for Alzheimer's Disease Classification from Structural MRI

cs.CV cs.AI ·2026-09-14 ·Paul-Gabriel Nicolae, Irina Georgiana Mocanu
theory similarity 0.64
Abstract · 13 pages, 4 figures

Deep networks trained on structural MRI for Alzheimer's disease (AD) staging often reach reasonable accuracy while attending to anatomically irrelevant regions, and multimodal models that add clinical tables frequently rely on variables that were used to assign the diagnostic label in the first place. We study both issues with a deliberately lightweight slice-based encoder (ResNet18 with a one-layer Transformer over slices) on 1,075 baseline T1-weighted scans from ADNI-1. First, we use FastSurfer segmentations as an anatomical reference: YOLOv8 models trained on segmentation-derived labels localize Alzheimer-relevant structures with mAP_50 above 0.96, and a Grad-CAM comparison shows that the image-only classifier frequently attends to the skull, orbits and background. Second, we adapt a CLIP-style image - tabular contrastive framework and organize ADNIMERGE variables along a label-leakage spectrum. Fusion with cognitive scores yields 87.3% three-way accuracy, which we treat as a leakage-driven upper bound rather than an imaging result; fusion with regional volumes yields 73.0%. We observe that the choice of contrastive target changes what the image encoder learns: on MCI vs. CN, the image-only head reaches 52.4% when the encoder is aligned to cognitive scores and 73.8\% when aligned to volumes, although no tabular input is used at inference. Third, restricting the input to a per-subject crop of the medial temporal lobe raises image-only three-way accuracy from 58.7% to 65.1%. All results come from single runs on a small balanced test set, and we report confidence intervals and the protocol differences that prevent direct comparison with published numbers.

0.16

A Generalizable Feature Extractor for Alzheimer's-Related Brain MRI Tasks

cs.CV q-bio.QM ·2026-09-04 ·Reza Rajabli, D. Louis Collins
similarity 0.63
Abstract · 26 pages (excluding the references section), 7 figures (excluding sub-figures)

When there is not enough labeled data to properly train deep learning models, transfer learning can help. We still do not fully understand how effective it is in neuroimaging, especially for Alzheimer's disease research. It is also not clear if these transferred models can work on new datasets without being retrained for each specific task. We evaluate whether a compact, supervised pretrained model can serve as a reusable foundation model for downstream neuroimaging tasks. We freeze the 7.18 million weights of a 3D CNN previously trained for brain-age prediction, and adapt it to each task using Low-Rank Adaptation (LoRA), requiring only ~1% additional trainable parameters. We evaluate generalizability in six experiments. Adapting the model to classify cognitively normal versus Dementia on ADNI gave an AUC of 0.964 on held-out folds (Experiment #1). Applying that adapted model unchanged to OASIS-3, with no retraining, gave an AUC of 0.871 (Experiment #2). Reusing its output logit together with age and a cognitive score distinguished stable from progressing MCI with an AUC of 0.828 (Experiment #3). Adapting the same backbone to predict amyloid positivity from structural MRI gave an AUC of 0.804 (Experiment #4). Finally, the same approach estimated ICV-normalized hippocampal and white matter hypointensity volumes directly from the T1w image, with R^2 of 0.80 and 0.91 respectively, tasks normally addressed with much larger U-Net networks (Experiments #5 and #6). A compact model supervised on brain age can therefore serve as a reusable backbone, adapting to each task with ~1% additional parameters and transferring to an unseen cohort without any training. Our findings suggest that a carefully trained brain age model can serve as an effective foundation model for Alzheimer's related tasks, even under strict data constraints.

0.18

A Multimodal Explainable Deep Learning Framework for Alzheimer's Disease Diagnosis using 3D Magnetic Resonance Imaging and Clinical Data

cs.CV stat.ML ·2026-09-11 ·Yusuf Brima, Marcellin Atemkeng, Lakshmana Rao Namamula, Antoine Vacavant
similarity 0.63
Abstract

Dementia is a major and growing global health burden, with Alzheimer's disease (AD) accounting for most cases. Timely and accurate diagnosis is central to managing this burden and increasingly depends on integrating complementary clinical and imaging information. Multimodal deep learning can combine these modalities for AD diagnosis, but how its explanations behave across modalities, fusion strategies, and cohorts remains unclear. We developed an explainable multimodal framework pairing a 3D CNN encoder for T1-weighted MRI with a feedforward network for harmonized clinical and demographic data, comparing varied model setups on three-way and pairwise diagnostic tasks using 6,479 internal records from the ADNI and 1,703 independent records from the OASIS-3. On ADNI, the tabular-only model achieved the highest three-class AUC-ROC of 0.879 and best discriminated cognitively normal (CN) versus mild cognitive impairment (MCI; 0.903), while cross-attention performed best for MCI versus AD (0.861); CN versus AD was highly discriminative overall. On OASIS-3, the vision-only model performed best (three-class AUC-ROC 0.910); CN versus MCI remained difficult, and no fusion strategy consistently outperformed single modalities across tasks and cohorts. SHAP and Integrated Gradients identified the MMSE as the dominant tabular feature in both cohorts, with global feature rankings agreeing strongly in ADNI ($ρ=0.94$) and OASIS-3 ($ρ=0.96$); CAM-based explanations, however, changed with model configuration and cohort. These findings show that multimodal performance and explanations are task, modality, fusion, and cohort-dependent: a dominant cognitive signal persisted across cohorts, but feature contributions and CAM explanations did not, underscoring the need to evaluate explainability under cohort shift rather than as a stable, intrinsic property.

0.10